Skip to content. | Skip to navigation

Garvan Institute

 
Sections
 

Cell Cycle Related News

 

Calculating how breast cancers will respond to tamoxifen

MEDIA RELEASE: 08 Sep 2008
A discovery by Garvan scientists should help clinicians decide which women with breast cancer will make good candidates for anti-oestrogen therapies, such as tamoxifen, and which will not.
 
 

Personal tools